Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation (Q38947873)

7 September 2017

Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation (English)

1 reference

7 September 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Rosaely Casalegno-Garduño

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Anita Schmitt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Alf Spitschak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jochen Greiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Lei Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Carsten Hirt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Anthony D Ho

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Mathias Freund

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Michael Schmitt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

31 October 2015

1 reference

International Journal of Cancer

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

1792-1801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

6 June 2020

cites work

1 reference

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

21 January 2018

1 reference

Clinical peptide vaccination trials for leukemia patients

21 January 2018

1 reference

Wilms' tumor 1 as a novel target for immunotherapy of leukemia

21 January 2018

1 reference

Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety

21 January 2018

1 reference

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

21 January 2018

1 reference

Wilms tumor gene expression in acute myeloid leukemias

21 January 2018

1 reference

Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status

21 January 2018

1 reference

Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells

21 January 2018

1 reference

Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

21 January 2018

1 reference

Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

21 January 2018

1 reference

WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions

21 January 2018

1 reference

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

21 January 2018

1 reference

Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis

21 January 2018

1 reference

Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

21 January 2018

1 reference

Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation

21 January 2018

1 reference

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

21 January 2018

1 reference

Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia.

21 January 2018

1 reference

Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.

21 January 2018

1 reference

Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity

21 January 2018

1 reference

Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.

21 January 2018

1 reference

Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia

21 January 2018

1 reference

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.

21 January 2018

1 reference

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

21 January 2018

1 reference

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

21 January 2018

1 reference

WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation

21 January 2018

1 reference

Donor lymphocyte infusion induces polyspecific CD8(+) T-cell responses with concurrent molecular remission in acute myeloid leukemia with NPM1 mutation

21 January 2018

1 reference

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

21 January 2018

1 reference

Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling

21 January 2018

1 reference

Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation

21 January 2018

1 reference

Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant

21 January 2018

1 reference

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy.

21 January 2018

1 reference

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

21 January 2018

1 reference

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells

21 January 2018

1 reference

High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens

21 January 2018

1 reference

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29909

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26519872%20AND%20SRC:MED&resulttype=core&format=json

release_yud65nao3bahxpbjaq76iiaz5y

6 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yud65nao3bahxpbjaq76iiaz5y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference